L. Christodoulou
发表
F. Fallah-Arani,
D. Humphreys,
M. Malmqvist,
2017,
Scientific Reports.
The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study
R. Lledo-Garcia,
S. Jolles,
F. Brennan,
2017,
Science Translational Medicine.
A. Shock,
F. Brennan,
D. Lightwood,
2019,
International immunopharmacology.
F. Fallah-Arani,
D. Humphreys,
M. Malmqvist,
2017,
Scientific Reports.
C. Meier,
A. Turner,
R. Lledo-Garcia,
2018,
mAbs.
A. Turner,
M. Ellis,
D. Humphreys,
2013,
Clinical and Vaccine Immunology.
A. Lawson,
A. Turner,
R. Adams,
2016,
mAbs.
R. Lindberg,
R. Liblau,
M. Pallardy,
2019,
Multiple sclerosis.